Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Gabriel Pereira Torrellas

Vascular Surgery Ponce, PR Medical Doctor

NPI 1427463116 CMS profile 1200802

909 Ave Tito Castro Torre Medica San Lucas, Ste 602, Ponce, PR 00716

Open in the dashboard

General payments

$9,004

171 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Gabriel Pereira Torrellas of Ponce, PR is reported in the CMS Open Payments database as having received $9,004 across 171 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 65th percentile of Vascular Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,020 69
2024 General $705 24
2023 General $1,098 23
2022 General $766 15
2021 General $2,913 16
2020 General $375 5
2019 General $1,129 19

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Gabriel Pereira Torrellas
  • Vascular Surgery median
  • Middle half of Vascular Surgery
  • National median

In program year 2025, general payments to Gabriel Pereira Torrellas were reported at $2,020. Among 3,991 Vascular Surgery profiles paid that year, the median was $924 and the middle half received between $273 and $2,636.

Show as a table
Year Gabriel Pereira Torrellas Vascular Surgery median Middle half National median
2019 $1,129 $796 $226–$2,363 $163
2020 $375 $348 $118–$1,110 $114
2021 $2,913 $471 $158–$1,421 $132
2022 $766 $725 $222–$2,183 $149
2023 $1,098 $836 $257–$2,440 $160
2024 $705 $909 $252–$2,619 $164
2025 $2,020 $924 $273–$2,636 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic, Inc. $4,097 45 payments
  2. Becton, Dickinson and Company $998 20 payments
  3. W. L. Gore & Associates, Inc. $696 13 payments
  4. Bard Peripheral Vascular, Inc. $666 14 payments
  5. Abbott Laboratories $509 38 payments
  6. Silk Road Medical, Inc. $443 6 payments
  7. Medtronic Vascular, Inc. $403 3 payments
  8. Cook Medical LLC $204 6 payments
  9. Boston Scientific Corporation $182 5 payments
  10. Terumo Medical Corporation $181 4 payments
  11. Other $626 17 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $6,104 162 payments
  2. Grant $1,667 1 payment
  3. Education $673 3 payments
  4. Travel and Lodging $561 5 payments
Products named General payments · program years 2019–2025
  1. Endurant $2,064 4 payments
  2. ENDURANT IIS $930 23 payments
  3. EXCLUDER Conformable AAA Endoprosthesis with Active Control $445 4 payments
  4. ENROUTE Transcarotid Stent $443 6 payments
  5. ENROUTE Transcarotid Neuroprotection System $443 6 payments
  6. VENOVO $308 4 payments
  7. Valiant Captivia $230 4 payments
  8. Sonicision $180 2 payments
  9. ARMADA $179 14 payments
  10. ENHANCE Transcarotid Peripheral Access Kit $174 3 payments
  11. Other $3,264 103 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 10 drugs

Part D claims

303

Median for Vascular Surgery: 122

Drug cost

$61,877

Median for Vascular Surgery: $14,135

Branded share of claims

66%

Median for Vascular Surgery: 71%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 55 $30,905
Xarelto Rivaroxaban Brand 45 $28,766
Cilostazol Generic 19 $581
Clopidogrel Clopidogrel Bisulfate Brand 58 $518
Atorvastatin Calcium Generic 45 $383
Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav Brand 14 $241
Warfarin Sodium Generic 11 $202
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 28 $169
Gabapentin Generic 15 $93
Diazepam Generic 13 $21

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 3,087 Part D prescribers listed as Vascular Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 40 billing codes

Paid by Medicare

$15,013

Medicare's payments for the services billed

Medicare patients

20

Average age 73

Services billed

122

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Diabetes 65%
Ischemic heart disease 55%
Alzheimer's or dementia 0%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

171 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular Surgery in Puerto Rico

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record